Our global manufacturing capabilities in complex formulations, high potency, and lyophilization covers a broad range of injectables including nanoparticles, mRNA, MABs, proteins, oligonucleotides, and other biologics across multiple delivery formats from vials and bottles to prefilled syringes and autoinjectors.
We provide integrated large and small molecule solutions for clinical and commercial projects, and with over 20 years in the sterile fill-finish and lyophilization manufacturing space, we are dedicated to the success of your life changing therapies.
Advanced Sterile Injectable Dosage Forms
Prefilled syringes are becoming one of the preferred formats for many injectable medications alongside autoinjectors, pens and on-body devices, and the fill-finish process of these delivery formats must ensure the highest sterility and quality standards to protect patient safety.
Prefilled syringes and other advanced injectable delivery formats offer several advantages over traditional vial-and-syringe systems including:
- Improved sterility and safety, lowering the risk of contamination or dosing errors
- Convenience and ease of use for healthcare professionals and patients, especially in self-administration
- Reduced drug waste, as the exact dose is pre-measured
PCI’s strategy over recent years has focussed on the development and manufacturing of specialized medicines, both highly potent oral dose and advanced sterile injectable products, with all dosage forms being supported by in-house analytical capabilities and extensive packaging solutions from development to commercial launch.
We’ve made sizable investments in recent years and experienced substantial organic growth in our sterile fill-finish service offering. As part of our strategy, enhancing our US capabilities in high potent sterile fill-finish to complement our oral dose capabilities, bolstering our clinical to commercial scale prefilled syringe service solutions in both the United States and Europe has been an important step in terms of meeting our customers’ ongoing needs.
Lyophilization and Sterile Manufacturing Services
Our dedicated team of specialists will be happy to discuss any of our Sterile Manufacturing Services with you. Contact us on +1 215-613-3600 (US) or +44 1495 711 222 (UK/EU) or email talkfuture@pci.com
Our development & manufacturing services
Talk to us about our world leading lyophilization cycle development services today.
Latest resources
Q&A
July 14, 2025
Article
June 30, 2025
Article
June 19, 2025
Q&A
June 17, 2025